A conceptual review on systems biology in health and diseases: from biological networks to modern therapeutics
暂无分享,去创建一个
[1] O. Ebenhöh,et al. Systems approaches to modelling pathways and networks. , 2011, Briefings in functional genomics.
[2] Rune Linding,et al. Directional and quantitative phosphorylation networks. , 2008, Briefings in functional genomics & proteomics.
[3] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..
[4] L. Hood,et al. Reverse Engineering of Biological Complexity , 2007 .
[5] G. Hays,et al. Identification of genetically and oceanographically distinct blooms of jellyfish , 2013, Journal of The Royal Society Interface.
[6] Rachael Hageman Blair,et al. Mathematical and Statistical Modeling in Cancer Systems Biology , 2012, Front. Physio..
[7] Avi Ma’ayan. Introduction to Network Analysis in Systems Biology , 2011, Science Signaling.
[8] Robert S Parker,et al. Dynamic modeling of free fatty acid, glucose, and insulin: an extended "minimal model". , 2006, Diabetes technology & therapeutics.
[9] C. Rao,et al. Control motifs for intracellular regulatory networks. , 2001, Annual review of biomedical engineering.
[10] D. Galas,et al. Diseases as network perturbations. , 2010, Current opinion in biotechnology.
[11] Devjit Tripathy,et al. Defects in Insulin Secretion and Action in the Pathogenesis of Type 2 Diabetes Mellitus , 2010, Current diabetes reports.
[12] Jacky L. Snoep,et al. BioModels Database: a free, centralized database of curated, published, quantitative kinetic models of biochemical and cellular systems , 2005, Nucleic Acids Res..
[13] Bernhard O Palsson,et al. Microbial regulatory and metabolic networks. , 2007, Current opinion in biotechnology.
[14] E. Chautard,et al. Interaction networks: from protein functions to drug discovery. A review. , 2009, Pathologie-biologie.
[15] A. De Gaetano,et al. Mathematical models of diabetes progression. , 2008, American journal of physiology. Endocrinology and metabolism.
[16] H. A. van den Berg,et al. Mathematical models of energy homeostasis , 2008, Journal of The Royal Society Interface.
[17] A. Barabasi,et al. Network medicine--from obesity to the "diseasome". , 2007, The New England journal of medicine.
[18] U. Alon. Biological Networks: The Tinkerer as an Engineer , 2003, Science.
[19] D. Geman,et al. Computational Medicine: Translating Models to Clinical Care , 2012 .
[20] Tohru Mizushima. [Identification of a molecular mechanism for actions of existing medicines and its application for drug development]. , 2012, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.
[21] Matthew A. Hibbs,et al. Visualization of omics data for systems biology , 2010, Nature Methods.
[22] David J. Klinke,et al. Integrating Epidemiological Data into a Mechanistic Model of Type 2 Diabetes: Validating the Prevalence of Virtual Patients , 2008, Annals of Biomedical Engineering.
[23] Mehmet Koyut. Algorithmic and analytical methods in network biology , 2009 .
[24] Barbara M. Bakker,et al. Emergence of the silicon human and network targeting drugs. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[25] O. Reséndis-Antonio,et al. Modeling Core Metabolism in Cancer Cells: Surveying the Topology Underlying the Warburg Effect , 2010, PloS one.
[26] Rakesh K Jain,et al. Can we identify predictive biomarkers for antiangiogenic therapy of cancer using mathematical modeling? , 2013, Journal of the National Cancer Institute.
[27] P. Aloy,et al. Unveiling the role of network and systems biology in drug discovery. , 2010, Trends in pharmacological sciences.
[28] Eduardo Sontag,et al. Untangling the wires: A strategy to trace functional interactions in signaling and gene networks , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[29] Meindert Danhof,et al. Disease System Analysis: Basic Disease Progression Models in Degenerative Disease , 2005, Pharmaceutical Research.
[30] Ronan M. T. Fleming,et al. Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0 , 2007, Nature Protocols.
[31] J. Ferrell. Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. , 2002, Current opinion in cell biology.
[32] Paolo Vicini. Kinetic models at the intersection of biology, engineering and medicine , 2008 .
[33] Ronan M. T. Fleming,et al. Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0 , 2007, Nature Protocols.
[34] S. Shen-Orr,et al. Network motifs: simple building blocks of complex networks. , 2002, Science.
[35] Xingming Zhao,et al. Computational Systems Biology , 2013, TheScientificWorldJournal.
[36] Hyun Uk Kim,et al. Data integration and analysis of biological networks. , 2010, Current opinion in biotechnology.
[37] Rui Jiang,et al. Constructing human phenome-interactome networks for the prioritization of candidate genes , 2012 .
[38] M. Vidal,et al. Integrating 'omic' information: a bridge between genomics and systems biology. , 2003, Trends in genetics : TIG.
[39] M. DePamphilis,et al. HUMAN DISEASE , 1957, The Ulster Medical Journal.
[40] E. Wang,et al. Dynamic modeling and analysis of cancer cellular network motifs. , 2011, Integrative biology : quantitative biosciences from nano to macro.
[41] J. Nielsen,et al. Translational and systems medicine , 2012, Journal of internal medicine.
[42] Ben van Ommen,et al. Nutritional Systems Biology Modeling: From Molecular Mechanisms to Physiology , 2009, PLoS Comput. Biol..
[43] Wolfgang Weiss,et al. A Computational Systems Biology Software Platform for Multiscale Modeling and Simulation: Integrating Whole-Body Physiology, Disease Biology, and Molecular Reaction Networks , 2011, Front. Physio..
[44] P. Bork,et al. Association of genes to genetically inherited diseases using data mining , 2002, Nature Genetics.
[45] K. Shaitan,et al. Dynamic proteomics in modeling of the living cell. Protein-protein interactions , 2009, Biochemistry (Moscow).
[46] B. Kholodenko. Cell-signalling dynamics in time and space , 2006, Nature Reviews Molecular Cell Biology.
[47] Edda Klipp,et al. Modeling mechanistic biological networks: An advanced Boolean approach , 2012, Bioinform..
[48] Christopher J. Oldfield,et al. Intrinsically disordered protein. , 2001, Journal of molecular graphics & modelling.
[49] S. Lee,et al. Metabolic network modeling and simulation for drug targeting and discovery , 2012, Biotechnology journal.
[50] Larry Norton,et al. Translating Mathematical Modeling of Tumor Growth Patterns into Novel Therapeutic Approaches for Breast Cancer , 2012, Journal of Mammary Gland Biology and Neoplasia.
[51] C R Scriver,et al. Monogenic traits are not simple: lessons from phenylketonuria. , 1999, Trends in genetics : TIG.
[52] E. Kunkel. Systems biology in drug discovery , 2004, Nature Biotechnology.
[53] H. Kaneto,et al. Transcription factors as therapeutic targets for diabetes. , 2008, Expert opinion on therapeutic targets.
[54] Alan F. Scott,et al. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2004, Nucleic Acids Res..
[55] Filippo Menolascina,et al. Engineering and control of biological systems: A new way to tackle complex diseases , 2012, FEBS letters.
[56] Edda Klipp,et al. Biochemical network-based drug-target prediction. , 2010, Current opinion in biotechnology.
[57] Yuan Qi,et al. Modularity and Dynamics of Cellular Networks , 2006, PLoS Comput. Biol..
[58] Alan F. Scott,et al. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2002, Nucleic Acids Res..
[59] M. Gerstein,et al. Getting connected: analysis and principles of biological networks. , 2007, Genes & development.
[60] Emma Saavedra,et al. Metabolic Control Analysis: A Tool for Designing Strategies to Manipulate Metabolic Pathways , 2008, Journal of biomedicine & biotechnology.
[61] Pall I. Olason,et al. A human phenome-interactome network of protein complexes implicated in genetic disorders , 2007, Nature Biotechnology.
[62] Ron Summers,et al. Engineering Biology: Model Conceptualisation and Realisation , 2011 .
[63] Tammy M. K. Cheng,et al. Understanding cancer mechanisms through network dynamics. , 2012, Briefings in functional genomics.
[64] Monika Heiner,et al. BioModel engineering for multiscale Systems Biology. , 2013, Progress in biophysics and molecular biology.
[65] P. J. Bhat,et al. Can metabolic plasticity be a cause for cancer? Warburg–Waddington legacy revisited , 2011, Clinical Epigenetics.
[66] U. Bhalla,et al. Emergent properties of networks of biological signaling pathways. , 1999, Science.
[67] A. Arkin,et al. Motifs, modules and games in bacteria. , 2003, Current opinion in microbiology.
[68] Gary D Bader,et al. Dynamic interaction networks in a hierarchically organized tissue , 2010, Molecular systems biology.
[69] Hiroyuki Ogata,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..
[70] J. Doyle,et al. Metabolic syndrome and robustness tradeoffs. , 2004, Diabetes.
[71] Mark A. J. Chaplain,et al. Mathematical modeling of cancer cell invasion of tissue: biological insight from mathematical analysis and computational simulation , 2011, Journal of mathematical biology.
[72] A. Barabasi,et al. The human disease network , 2007, Proceedings of the National Academy of Sciences.
[73] J. Houtman,et al. Examining multiprotein signaling complexes from all angles , 2005, The FEBS journal.
[74] G. Saidel,et al. Multi-Scale Computational Model of Fuel Homeostasis During Exercise: Effect of Hormonal Control , 2006, Annals of Biomedical Engineering.
[75] I. Lavrik,et al. Mathematical modeling of apoptosis , 2013, Cell Communication and Signaling.
[76] Gilles Clermont,et al. Computational disease modeling – fact or fiction? , 2009, BMC Systems Biology.
[77] Lopamudra Giri,et al. A steady state analysis indicates that negative feedback regulation of PTP1B by Akt elicits bistability in insulin-stimulated GLUT4 translocation , 2004, Theoretical Biology and Medical Modelling.
[78] Kevin A. Janes,et al. Multiscale Models of Cell Signaling , 2012, Annals of Biomedical Engineering.
[79] Jeffrey D Orth,et al. What is flux balance analysis? , 2010, Nature Biotechnology.
[80] Carol Friedman,et al. Discovery of Protein Interaction Networks Shared by Diseases , 2006, Pacific Symposium on Biocomputing.
[81] Alfio Quarteroni,et al. A vision and strategy for the virtual physiological human: 2012 update , 2013, Interface Focus.
[82] Claudio Cobelli,et al. Meal Simulation Model of the Glucose-Insulin System , 2007, IEEE Transactions on Biomedical Engineering.
[83] A. Bauer-Mehren,et al. Pathway databases and tools for their exploitation: benefits, current limitations and challenges , 2009, Molecular systems biology.
[84] Ewart R. Carson,et al. Modelling and control in biomedical systems , 2011, Comput. Methods Programs Biomed..
[85] Yang Kuang,et al. Mathematical models and software tools for the glucose-insulin regulatory system and diabetes: an overview , 2006 .
[86] Tsviya Olender,et al. Human Gene-Centric Databases at the Weizmann Institute of Science: GeneCards, UDB, CroW 21 and HORDE , 2003, Nucleic Acids Res..
[87] Yoshihiro Ogawa,et al. Integrated network systems and evolutionary developmental endocrinology. , 2010, Medical hypotheses.
[88] D. Wilkinson. Stochastic modelling for quantitative description of heterogeneous biological systems , 2009, Nature Reviews Genetics.
[89] Teresa M Przytycka,et al. Network integration meets network dynamics , 2010, BMC Biology.
[90] D. K. Arrell,et al. Network Systems Biology for Drug Discovery , 2010, Clinical pharmacology and therapeutics.
[91] Vittorio Cristini,et al. Multiscale cancer modeling. , 2010, Annual review of biomedical engineering.
[92] Andrei Zinovyev,et al. Cell death and life in cancer: mathematical modeling of cell fate decisions. , 2013, Advances in experimental medicine and biology.
[93] B. Mayer. Protein-protein interactions in signaling cascades. , 1998, Methods in molecular biology.
[94] M. Peitsch,et al. The application of systems biology to drug discovery. , 2006, Current opinion in chemical biology.
[95] R. Sharan,et al. Protein networks in disease. , 2008, Genome research.
[96] Hans-Dieter Pohlenz,et al. PhenomicDB: a multi-species genotype/phenotype database for comparative phenomics , 2005, Bioinform..
[97] Victor Neduva,et al. Peptides mediating interaction networks: new leads at last. , 2006, Current opinion in biotechnology.
[98] B. Kholodenko,et al. Computational Approaches for Analyzing Information Flow in Biological Networks , 2012, Science Signaling.
[99] S. Sestini,et al. Genetic studies of diseases , 2007, Cellular and Molecular Life Sciences.
[100] U. Alon. Network motifs: theory and experimental approaches , 2007, Nature Reviews Genetics.
[101] J. Stelling,et al. Robustness of Cellular Functions , 2004, Cell.
[102] Cheng-Liang Chen,et al. Modeling the physiological glucose-insulin dynamic system on diabetics. , 2010, Journal of theoretical biology.
[103] P. Clemons,et al. Target identification and mechanism of action in chemical biology and drug discovery. , 2013, Nature chemical biology.
[104] Fusheng Tang,et al. A molecular mathematical model of glucose mobilization and uptake. , 2009, Mathematical biosciences.
[105] K.G. Gadkar,et al. Towards Optimal Virtual Patients: An Online Adaptive Control Approach , 2007, 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[106] Alexandra Piryatinska,et al. Mathematical modeling of tumor cell proliferation kinetics and label retention in a mouse model of lung cancer. , 2013, Cancer research.
[107] D. F. Waugh,et al. Protein-protein interactions. , 1954, Advances in protein chemistry.
[108] Peter Hunter,et al. Integration from proteins to organs: the IUPS Physiome Project , 2005, Mechanisms of Ageing and Development.
[109] Hiroaki Kitano,et al. Structure of Protein Interaction Networks and Their Implications on Drug Design , 2009, PLoS Comput. Biol..
[110] John Hornberger,et al. Computer Modeling of Diabetes and Its Complications , 2007, Diabetes Care.
[111] N H Holford,et al. Drug treatment effects on disease progression. , 2001, Annual review of pharmacology and toxicology.
[112] Lee Suan Chua,et al. Modeling of glucose regulation and insulin-signaling pathways , 2009, Molecular and Cellular Endocrinology.
[113] Edwin Wang,et al. A Roadmap of Cancer Systems Biology , 2010 .
[114] G. D. Gatta,et al. Systems and Synthetic biology: tackling genetic networks and complex diseases , 2009, Heredity.
[115] Antonio Bertoletti,et al. The Host–pathogen Interaction during HBV Infection: Immunological Controversies , 2010, Antiviral therapy.
[116] Nagasuma Chandra,et al. Computational systems approach for drug target discovery , 2009, Expert opinion on drug discovery.
[117] V. Uversky. Intrinsically Disordered Proteins , 2014 .
[118] Kiran Raosaheb Patil,et al. Metabolic Network Topology Reveals Transcriptional Regulatory Signatures of Type 2 Diabetes , 2010, PLoS Comput. Biol..
[119] Richard N Bergman,et al. The minimal model of glucose regulation: a biography. , 2003, Advances in experimental medicine and biology.
[120] J. Ferrell,et al. Interlinked Fast and Slow Positive Feedback Loops Drive Reliable Cell Decisions , 2005, Science.
[121] C. Ouzounis,et al. Expansion of the BioCyc collection of pathway/genome databases to 160 genomes , 2005, Nucleic acids research.
[122] Maricel G. Kann,et al. Protein interactions and disease: computational approaches to uncover the etiology of diseases , 2007, Briefings Bioinform..
[123] A. Barabasi,et al. Drug—target network , 2007, Nature Biotechnology.
[124] J. Hopfield,et al. From molecular to modular cell biology , 1999, Nature.
[125] H. Kitano. Towards a theory of biological robustness , 2007, Molecular systems biology.
[126] Dongqing Wei,et al. Progress in the applications of flux analysis of metabolic networks , 2010 .
[127] A. Sherman,et al. A mathematical model of metabolic insulin signaling pathways. , 2002, American journal of physiology. Endocrinology and metabolism.
[128] Jan A M Raaijmakers,et al. Systems biology in pharmacogenomic research: the way to personalized prescribing? , 2009, Pharmacogenomics.
[129] Hulin Wu,et al. Multi-scale agent-based modeling on melanoma and its related angiogenesis analysis , 2013, Theoretical Biology and Medical Modelling.
[130] Nathan D. Price,et al. Mechanistic modeling of aberrant energy metabolism in human disease , 2012, Front. Physio..
[131] P. S. Thiagarajan,et al. Modeling and Analysis of biopathways Dynamics , 2012, J. Bioinform. Comput. Biol..
[132] F. Rosselli,et al. 3R coordination by Fanconi anemia proteins. , 2005, Biochimie.
[133] Michael Ederer,et al. Reduced modeling of signal transduction – a modular approach , 2007, BMC Bioinformatics.
[134] Gert Vriend,et al. GeneSeeker: extraction and integration of human disease-related information from web-based genetic databases , 2005, Nucleic Acids Res..
[135] Shayn M Peirce,et al. Multiscale computational models of complex biological systems. , 2013, Annual review of biomedical engineering.
[136] A. Mardinoğlu,et al. Systems medicine and metabolic modelling , 2012, Journal of internal medicine.
[137] Frances S. Turner,et al. Computational disease gene identification: a concert of methods prioritizes type 2 diabetes and obesity candidate genes , 2006, Nucleic acids research.
[138] Sarah R. Langley,et al. Proteomics: from single molecules to biological pathways , 2012, Cardiovascular research.
[139] Jason A. Papin,et al. Reconstruction of cellular signalling networks and analysis of their properties , 2005, Nature Reviews Molecular Cell Biology.
[140] Florian Nigsch,et al. Recent trends and observations in the design of high-quality screening collections. , 2011, Future medicinal chemistry.
[141] D. Butler. Computing 2010: from black holes to biology , 1999, Nature.
[142] Ian David Lockhart Bogle,et al. The role of Computer Aided Process Engineering in physiology and clinical medicine , 2010, Comput. Chem. Eng..
[143] C. Cobelli,et al. Glucose effectiveness and insulin sensitivity from the minimal models: consequences of undermodeling assessed by Monte Carlo simulation , 1999, IEEE Transactions on Biomedical Engineering.
[144] Nagasuma R. Chandra,et al. Metabolome Based Reaction Graphs of M. tuberculosis and M. leprae: A Comparative Network Analysis , 2007, PloS one.
[145] Michael B. Yaffe,et al. Data-driven modelling of signal-transduction networks , 2006, Nature Reviews Molecular Cell Biology.
[146] H. Häring,et al. [Pathophysiology of insulin resistance]. , 1995, Herz.
[147] V. Shahrezaei,et al. The stochastic nature of biochemical networks. , 2008, Current opinion in biotechnology.
[148] E. Wang,et al. Genetic studies of diseases , 2007, Cellular and Molecular Life Sciences.
[149] Jason A. Papin,et al. Applications of genome-scale metabolic reconstructions , 2009, Molecular systems biology.
[150] Markus J. Herrgård,et al. Reconstruction of microbial transcriptional regulatory networks. , 2004, Current opinion in biotechnology.
[151] A. Barabasi,et al. The impact of cellular networks on disease comorbidity , 2009, Molecular systems biology.
[152] Wei Jiang,et al. The analysis of the drug–targets based on the topological properties in the human protein–protein interaction network , 2009, Journal of drug targeting.
[153] Christopher L. McClendon,et al. Reaching for high-hanging fruit in drug discovery at protein–protein interfaces , 2007, Nature.
[154] Stephen Coombes,et al. Mathematical Modeling of Glucose Homeostasis and Its Relationship With Energy Balance and Body Fat , 2009, Obesity.
[155] L. Lesko,et al. Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. , 2001, Annual review of pharmacology and toxicology.
[156] P. Aloy,et al. A network medicine approach to human disease , 2009, FEBS letters.
[157] H. Kitano. Systems Biology: A Brief Overview , 2002, Science.
[158] R. Linding,et al. Network‐based drugs and biomarkers , 2010, The Journal of pathology.
[159] F. Jordán,et al. Studying protein-protein interaction networks: a systems view on diseases. , 2012, Briefings in functional genomics.
[160] D. Botstein,et al. Construction of a genetic linkage map in man using restriction fragment length polymorphisms. , 1980, American journal of human genetics.
[161] Zhiwei Wang,et al. Proof of Concept: Network and Systems Biology Approaches Aid in the Discovery of Potent Anticancer Drug Combinations , 2010, Molecular Cancer Therapeutics.
[162] Hélène Decornez,et al. Early phase drug discovery: cheminformatics and computational techniques in identifying lead series. , 2012, Bioorganic & medicinal chemistry.
[163] James A. Eddy,et al. In silico models of cancer , 2010, Wiley interdisciplinary reviews. Systems biology and medicine.
[164] D. Moller,et al. New drug targets for type 2 diabetes and the metabolic syndrome , 2001, Nature.
[165] Ping Zhang,et al. Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood challenge meeting. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[166] Kathy Chen,et al. Network dynamics and cell physiology , 2001, Nature Reviews Molecular Cell Biology.
[167] Mehmet Koyutürk. Algorithmic and analytical methods in network biology , 2010, Wiley interdisciplinary reviews. Systems biology and medicine.
[168] Caitlin Smith,et al. A question of form , 2003, Nature.
[169] Obert,et al. A Model of b-Cell Mass , Insulin , and Glucose Kinetics : Pathways to Diabetes , 2000 .
[170] Arne Traulsen,et al. A deterministic model for the occurrence and dynamics of multiple mutations in hierarchically organized tissues , 2013, Journal of The Royal Society Interface.
[171] Bernhard O. Palsson,et al. The human metabolic reconstruction Recon 1 directs hypotheses of novel human metabolic functions , 2011, BMC Systems Biology.
[172] D. Lauffenburger,et al. Applying computational modeling to drug discovery and development. , 2006, Drug discovery today.
[173] S. Leibler,et al. Robustness in simple biochemical networks , 1997, Nature.
[174] R. Miura,et al. A Model of β -Cell Mass, Insulin, and Glucose Kinetics: Pathways to Diabetes , 2000 .